Increasing Awareness of Fertility Options: The Impact of Transportation Advertising on Meeta's Searches

Increasing Awareness of Fertility Options

In recent years, Pascreate Inc., headquartered in Shinjuku, Tokyo, has made significant strides in raising awareness about fertility options through an innovative approach—transportation advertising. With their primary product, the fertility timing method kit "Meeta (ミータ)シリンジ," they aim to expand knowledge about fertility choices available to couples hoping to conceive.

Starting from December 2025, Pascreate has been rolling out transportation advertisements in major cities, including Tokyo, as part of their strategy to boost recognition of Meeta. Notable routes include the Tokyo Metropolitan Transportation’s Oedo Line, Mita Line, Shinjuku Line, and Asakusa Line, among others. By July 2026, the search volume for Meeta surged dramatically—an impressive 250% compared to the same month the previous year. Online sales figures also reflected positive growth, jumping 142% year-on-year.

This trend suggests that increasing opportunities for potential customers to encounter information about fertility methods during their daily trips can foster actions such as "learning," "researching," and ultimately "choosing" their preferred options. In this article, we will delve into the transportation advertising initiatives undertaken so far and reflect on their impact, emphasizing the importance of expanding opportunities for couples to learn about fertility options.

Background: Creating Opportunities Beyond Reaction

Traditionally, individuals seeking fertility or infertility treatment information tend to do so during moments of urgency. There is, however, a crucial need to create awareness about the options available before such pressing times arise. Recent data from the Ministry of Health, Labor and Welfare indicates that 22.7% of couples have undergone or are currently undergoing infertility testing or treatment. Amidst the evolution of workplace and societal understanding of fertility issues, it is vital for companies like Pascreate to generate opportunities for awareness and discovery regarding fertility methods as part of a broader initiative for knowledge sharing.

By passively coming across information in everyday life, individuals can realize, "Hey, this is also an option." This encounter often inspires them to conduct their own research, ultimately leading them to select the approach that best fits their circumstances.

To achieve this, Pascreate has enhanced its digital outreach with online ads and social media, in addition to rolling out its transportation advertising campaign, which began in December 2025.

The Meeta Timing Method Kit

The "Meetaシリンジ" is a home-use fertility support kit classified as a general medical device. This product has gained heightened interest as an emerging fertility aid, designed for use at home under medical supervision to complement natural timing methods. The kit's design considers the physique of Japanese women and simplifies usage into three easy steps, requiring no special knowledge or equipment—all while catering to individual differences in experience.

Changes Observed During the Advertising Campaign

By July 2026, a notable spike in searches for Meeta was recorded, with an increase of 189% compared to the previous month, and an astonishing 250% increase relative to the same month the year before. This boom coincided with transportation ads featured across four subway lines in Tokyo and on the Nagoya City Subway.

The surge in search activity and online sales indicates that encountering options like "Meeta" and "the syringe method" in public spaces likely prompts interested individuals to seek further information and consider products more critically.

Future Prospects

The current initiative reveals that to deliver crucial fertility information effectively, businesses must reach not only those already searching for assistance but also create opportunities for potential users to become curious. Transportation ads serve as a vital touchpoint, engaging individuals in everyday life while highlighting available fertility options.

Moving forward, Pascreate is dedicated to continuing transportation advertising not merely as a promotional effort but as a means to provide opportunities for individuals to learn, research, and select fertility solutions. The goal is to diminish instances of individuals saying, "I didn’t know and therefore couldn’t choose,” thus empowering aspiring parents to recognize and choose methods that are right for them.

Company Overview

Founded on November 25, 2008, Pascreate Inc. is located at 1-8-4 Shinjuku, Kintetsu Shinjuku Gyoen Building 9F, Tokyo. The company specializes in the planning, development, and sales of healthcare products, along with operating owned media, providing talent dispatch services, and conducting online education programs. Pascreate Inc. holds two medical device licenses, indicating their compliance with established medical standards.